The DOI matches its Crossref record; 53 of the 53 references it cites were found in a registry or an index.
Reverse transcriptase-PCR quantification of mRNA levels from cytochrome (CYP)1, CYP2 and CYP3 families in 22 different human tissues
Abstract
OBJECTIVE: The aim of this work was to study simultaneously the expression profile of the 23 CYP mRNAs of CYP1, CTP2 and CYP3 families in 22 different human tissues namely adrenal gland, bladder, bone marrow, colon, fetal liver, heart, kidney, liver, lung, mammary gland, ovary, placenta, prostate, salivary gland, skeletal muscle, small intestine, spleen, testis, thymus, thyroid, trachea and uterus. METHODS: Analysis of the mRNA levels of each of these CYP isoforms was performed on total RNA from pooled specimens of human organs using reverse transcriptase-PCR-based CYP mRNA assays previously validated for their sensitivity and their specificity. RESULTS: Our results confirmed previously reported data in the literature concerning isoforms expression in the most currently studied tissues. Moreover, they provided a great deal of new information, mainly about the expression of mRNA of little-known CYP isoforms. Among the 23 CYP isoforms studied, 12 were mainly hepatic (CYP1A2, 2A6, 2A7, 2A13, 2C8, 2C9, 2C18, 2C19, 2D6, 2E1, 3A4 and 3A43). Two CYP mRNAs were predominantly expressed in several extrahepatic tissues: CYP1B1 mRNA was the predominant CYP in seven extrahepatic tissues (bone marrow, kidney, mammary gland, prostate, spleen, thyroid and uterus) and CYP2J2 in four extrahepatic tissues (heart, placenta, salivary gland and skeletal muscle). Finally, some CYPs were nearly exclusively expressed in only one extrahepatic tissue. CYP2R1 was found in testis, CYP2U1 in the thymus and CYP2F1 in the respiratory tract (lung and trachea). CONCLUSION: This description will broaden the understanding of the physiological functions of these CYPs.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Multiple sequence alignment with hierarchical clustering
Corpet, F. (1988) · Nucleic Acids Research · doi:10.1093/nar/16.22.10881 · Cited by 5,393
Shimada, T., Yamazaki, H., Mimura, M., Inui, Y., & Guengerich, F. P. (1994) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)22379-5 · Cited by 2,785
Clinical importance of the cytochromes P450
Nebert, D. W., & Russell, D. W. (2002) · The Lancet · doi:10.1016/s0140-6736(02)11203-7 · Cited by 1,414
Drug Metabolism and Variability among Patients in Drug Response
Wilkinson, G. R. (2005) · New England Journal of Medicine · doi:10.1056/nejmra032424 · Cited by 1,185
Nelson, D. R., Zeldin, D. C., Hoffman, S. M., Maltais, L. J., Wain, H. M., & Nebert, D. W. (2004) · Pharmacogenetics · doi:10.1097/00008571-200401000-00001 · Cited by 1,027
Ding, X., & Kaminsky, L. S. (2003) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.43.100901.140251 · Cited by 822
Activation of chemically diverse procarcinogens by human cytochrome P-450 1B1.
Shimada, T., Hayes, C. L., Yamazaki, H., et al. (1996) · PubMed · Cited by 793
The Cytochrome P450 Superfamily: Biochemistry, Evolution and Drug Metabolism in Humans
P.B. Danielson, B. S. P. (2002) · Current Drug Metabolism · doi:10.2174/1389200023337054 · Cited by 772
Genetic evidence that the human CYP2R1 enzyme is a key vitamin D 25-hydroxylase
Cheng, J. B., Levine, M. A., Bell, N. H., Mangelsdorf, D. J., & Russell, D. W. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0402490101 · Cited by 762
Epoxygenase Pathways of Arachidonic Acid Metabolism
Zeldin, D. C. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.r100030200 · Cited by 654
17 beta-estradiol hydroxylation catalyzed by human cytochrome P450 1B1.
Hayes, C. L., Spink, D. C., Spink, B. C., Cao, J. Q., Walker, N. J., & Sutter, T. R. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.18.9776 · Cited by 632
Cytochrome P450-mediated metabolism of estrogens and its regulation in human
Tsuchiya, Y., Nakajima, M., & Yokoi, T. (2005) · Cancer Letters · doi:10.1016/j.canlet.2004.10.007 · Cited by 616
Capdevila, J. H., Falck, J. R., & Harris, R. C. (2000) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)32049-6 · Cited by 552
Tumor-specific expression of cytochrome P450 CYP1B1.
Murray, G. I., Taylor, M. C., McFadyen, M. C. E., McKay, J., Greenlee, W. F., Burke, M. D., & Melvin, W. T. (1997) · PubMed · Cited by 532
de Waziers, I., Cugnenc, P. H., Yang, C. S., Leroux, J. P., & Beaune, P. H. (1990) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)12474-9 · Cited by 502
Self-citationWu, S., Moomaw, C. R., Tomer, K. B., Falck, J. R., & Zeldin, D. C. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.7.3460 · Cited by 473
Laborda, J. (1991) · Nucleic Acids Research · doi:10.1093/nar/19.14.3998 · Cited by 427
Cytochrome P450 and Vascular Homeostasis
Fleming, I. (2001) · Circulation Research · doi:10.1161/hh2101.099268 · Cited by 383
Weisglas-Kuperus, N., Patandin, S., Berbers, G. A., Sas, T. C., Mulder, P. G., Sauer, P. J., & Hooijkaas, H. (2000) · Environmental Health Perspectives · doi:10.1289/ehp.001081203 · Cited by 383
Expression and Regulation of Xenobiotic-Metabolizing Cytochrome P450 (CYP) Enzymes in Human Lung
Hukkanen, J., Pelkonen, O., Hakkola, J., & Raunio, H. (2002) · Critical Reviews in Toxicology · doi:10.1080/20024091064273 · Cited by 318
NISHIMURA, M., YAGUTI, H., YOSHITSUGU, H., NAITO, S., & SATOH, T. (2003) · YAKUGAKU ZASSHI · doi:10.1248/yakushi.123.369 · Cited by 313
Chapter 2: The Role of Steroid Hormones in Prostate Carcinogenesis
Bosland, M. C. (2000) · JNCI Monographs · doi:10.1093/oxfordjournals.jncimonographs.a024244 · Cited by 307
EFFECT OF CYP3A5 POLYMORPHISM ON TACROLIMUS METABOLIC CLEARANCE IN VITRO
Dai, Y., Hebert, M. F., Isoherranen, N., Davis, C. L., Marsh, C., Shen, D. D., & Thummel, K. E. (2006) · Drug Metabolism and Disposition · doi:10.1124/dmd.105.008680 · Cited by 279
57 Varieties: The Human Cytochromes P450
Lewis, D. F. (2004) · Pharmacogenomics · doi:10.1517/phgs.5.3.305.29827 · Cited by 277
Selective expression of cytochrome P450 CYP3A mRNAs in embryonic and adult human liver
Schuetz, J. D., Beach, D. L., & Guzelian, P. S. (1994) · Pharmacogenetics · doi:10.1097/00008571-199402000-00002 · Cited by 273
Choudhary, D., Jansson, I., Stoilov, I., Sarfarazi, M., & Schenkman, J. B. (2005) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2005.02.001 · Cited by 261
Liehr, J. G., Ricci, M. J., Jefcoate, C. R., Hannigan, E. V., Hokanson, J. A., & Zhu, B. T. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.20.9220 · Cited by 208
Chuang, S. S., Helvig, C., Taimi, M., Ramshaw, H. A., Collop, A. H., Amad, M., White, J. A., Petkovich, M., Jones, G., & Korczak, B. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m311830200 · Cited by 182
Cytochrome P450 enzymes: Central players in cardiovascular health and disease
Elbekai, R. H., & El-Kadi, A. O. S. (2006) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2005.05.011 · Cited by 181
Expression of the tumor suppressor gene Maspin in human pancreatic cancers.
Maass, N., Hojo, T., Ueding, M., Lüttges, J., Klöppel, G., Jonat, W., & Nagasaki, K. (2001) · PubMed · Cited by 167
The role of cytochrome P450 enzymes in hepatic and extrahepatic human drug toxicity
Park, B. K., Pirmohamed, M., & Kitteringham, N. R. (1995) · Pharmacology & Therapeutics · doi:10.1016/0163-7258(95)02013-6 · Cited by 161
Smith, G. C., Wolf, C. R., Deeni, Y., Dawe, R. S., Evans, A. T., Comrie, M., Ferguson, J., & Ibbotson, S. H. (2003) · The Lancet · doi:10.1016/s0140-6736(03)13081-4 · Cited by 153
Identification of a novel dioxin-inducible cytochrome P450
Rivera, S. P., Saarikoski, S. T., & Hankinson, O. (2002) · Molecular Pharmacology · doi:10.1016/s0026-895x(24)12856-8 · Cited by 149
Quantification of estrogen receptor α and β expression in sporadic breast cancer
Bièche, I., Parfait, B., Laurendeau, I., Girault, I., Vidaud, M., & Lidereau, R. (2001) · Oncogene · doi:10.1038/sj.onc.1204917 · Cited by 148
Self-citationZeldin, D. C., Foley, J. F., Goldsworthy, S. M., Cook, M. E., Boyle, J. E., Ma, J., Moomaw, C. R., Tomer, K. B., Steenbergen, C., & Wu, S. (1997) · Molecular Pharmacology · doi:10.1124/mol.51.6.931 · Cited by 135
Function of human cytochrome P450s: Characterization of the orphans
Guengerich, F. P., Wu, Z., & Bartleson, C. (2005) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2005.08.079 · Cited by 133
Tumour Cytochrome P450 and Drug Activation
Patterson, L. H., & Murray, G. I. (2002) · Current Pharmaceutical Design · doi:10.2174/1381612023394502 · Cited by 126
Tumor-specific expression of the novel cytochrome P450 enzyme, CYP2W1
Karlgren, M., Gomez, A. V., Stark, K., Svärd, J., Rodríguez‐Antona, C., Oliw, E. H., Bernal, M. L., y Cajal, S. R., Johansson, I., & Ingelman‐Sundberg, M. (2006) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2005.12.200 · Cited by 115
Involvement of CYP2J2 on the Intestinal First-Pass Metabolism of Antihistamine Drug, Astemizole
Matsumoto, S., Hirama, T., Matsubara, T., Nagata, K., & Yamazoe, Y. (2002) · Drug Metabolism and Disposition · doi:10.1124/dmd.30.11.1240 · Cited by 113
Saarikoski, S. T., Rivera, S. P., Hankinson, O., & Husgafvel‐Pursiainen, K. (2005) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2004.12.027 · Cited by 112
DO MEN AND WOMEN DIFFER IN PROXIMAL SMALL INTESTINAL CYP3A OR P-GLYCOPROTEIN EXPRESSION?
Paine, M. F., Ludington, S. S., Chen, M.-L., Stewart, P. W., Huang, S.-M., & Watkins, P. B. (2004) · Drug Metabolism and Disposition · doi:10.1124/dmd.104.002469 · Cited by 108
Sesardic, D., Pasanen, M., Pelkonen, O., & Boobis, A. R. (1990) · Carcinogenesis · doi:10.1093/carcin/11.7.1183 · Cited by 107
Identification and Tissue Distribution of the Novel Human Cytochrome P450 2S1 (CYP2S1)
Rylander‐Rudqvist, T., Neve, E. P. A., Ingelman‐Sundberg, M., & Oscarson, M. (2001) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2001.4390 · Cited by 106
Novel extrahepatic cytochrome P450s
Karlgren, M., MIURA, S., & Ingelman‐Sundberg, M. (2005) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2004.12.022 · Cited by 101
Regulation of cytochrome P450 genes: molecular mechanisms
Gonzalez, F. J., Liu, S., & Yano, M. (1993) · Pharmacogenetics · doi:10.1097/00008571-199302000-00006 · Cited by 99
Imaoka, S., Hashizume, T., & Funae, Y. (2005) · Drug Metabolism and Pharmacokinetics · doi:10.2133/dmpk.20.478 · Cited by 83
Sumida, A., Kinoshita, K., Fukuda, T., Matsuda, H., Yamamoto, I., Inaba, T., & Azuma, J. (1999) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1999.1233 · Cited by 82
TRANSCRIPTIONAL ACTIVATION OF CYTOCHROME P450 GENES BY DIFFERENT CLASSES OF CHEMICAL INDUCERS
Dogra, S. C., Whitelaw, M. L., & May, B. K. (1998) · Clinical and Experimental Pharmacology and Physiology · doi:10.1111/j.1440-1681.1998.tb02135.x · Cited by 78
Characterization and tissue distribution of a novel human cytochrome P450—CYP2U1
Karlgren, M., Backlund, M., Johansson, I., Oscarson, M., & Ingelman‐Sundberg, M. (2004) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2004.01.110 · Cited by 68
Cytochrome P450 in Neurological Disease
Liu, M., Hurn, P. D., & Alkayed, N. J. (2004) · Current Drug Metabolism · doi:10.2174/1389200043335540 · Cited by 56
Andersen, M. R., Farin, F. M., & Omiecinski, C. J. (1998) · DNA and Cell Biology · doi:10.1089/dna.1998.17.231 · Cited by 46
Wang, S., He, X., & Hong, J. (2004) · Drug Metabolism and Disposition · doi:10.1124/dmd.104.002923 · Cited by 37
Girault, I., Lerebours, F., Tozlu, S., Spyratos, F., Tubiana-Hulin, M., Lidereau, R., & Bièche, I. (2002) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/s0960-0760(02)00190-5 · Cited by 29
Self-citation
Cited by
Zanger, U. M., & Schwab, M. (2013) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2012.12.007 · Cited by 4,169
Metabolism pathways of arachidonic acids: mechanisms and potential therapeutic targets
Wang, B., Wu, L., Chen, J., Dong, L., Chen, C., Wen, Z., Hu, J., Fleming, I., & Wang, D. W. (2021) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-020-00443-w · Cited by 1,414
Fluorogenic probes for disease-relevant enzymes
Zhang, J., Chai, X., He, X.-P., Kim, H.-J., Yoon, J., & Tian, H. (2019) · Chemical Society Reviews · doi:10.1039/c7cs00907k · Cited by 606
Gut instincts: Explorations in intestinal physiology and drug delivery
McConnell, E. L., Fadda, H. M., & Basit, A. W. (2008) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2008.05.012 · Cited by 431
The ontogeny of drug metabolism enzymes and implications for adverse drug events
Hines, R. N. (2008) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2008.02.005 · Cited by 410
Metadata
- Authors
- Bièche, I., Narjoz, C., Asselah, T., Vacher, S., Marcellin, P., Lidereau, R., Beaune, P., & de Waziers, I.
- Venue
- Pharmacogenetics and Genomics
- Published
- 2007-09
- Volume
- 17
- Issue
- 9
- Pages
- 731-742
- ISSN
- 1744-6872 (ISSN-L)
- OpenAlex
- W2041956619
- Cited by
- 341
- References
- 53
- FWCI
- 16.65
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.